80 related articles for article (PubMed ID: 2047580)
1. Hypolipidemic effect of metrifonate and the relationship to serum cholinesterase inhibition.
Udom CE; Smith TJ
Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):387-90. PubMed ID: 2047580
[TBL] [Abstract][Full Text] [Related]
2. Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits.
Kronforst-Collins MA; Moriearty PL; Ralph M; Becker RE; Schmidt B; Thompson LT; Disterhoft JF
Pharmacol Biochem Behav; 1997 Jan; 56(1):103-10. PubMed ID: 8981616
[TBL] [Abstract][Full Text] [Related]
3. Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.
Hinz V; Grewig S; Schmidt BH
Neurochem Res; 1996 Mar; 21(3):339-45. PubMed ID: 9139240
[TBL] [Abstract][Full Text] [Related]
4. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
van der Staay FJ; Hinz VC; Schmidt BH
J Pharmacol Exp Ther; 1996 Aug; 278(2):697-708. PubMed ID: 8768721
[TBL] [Abstract][Full Text] [Related]
5. Effect of a single oral dose of metrifonate on human plasma cholinesterase levels.
Nhachi CF; Murambiwa W; Kasilo OJ; Gwanzura L; Mason P
Bull Environ Contam Toxicol; 1991 Nov; 47(5):641-5. PubMed ID: 1813075
[No Abstract] [Full Text] [Related]
6. The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate.
Heinig R; Sachse R
Int J Clin Pharmacol Ther; 1999 Sep; 37(9):456-64. PubMed ID: 10507245
[TBL] [Abstract][Full Text] [Related]
7. Metrifonate in healthy volunteers: interrelationship between pharmacokinetic properties, cholinesterase inhibition and side-effects.
Aden-Abdi Y; Villén T; Ericsson O; Gustafsson LL; Dahl-Puustinen ML
Bull World Health Organ; 1990; 68(6):731-6. PubMed ID: 2073711
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic metrifonate treatment on cholinergic enzymes and the blood-brain barrier.
Rakonczay Z; Papp H
Neurochem Int; 2001 Jul; 39(1):19-24. PubMed ID: 11311445
[TBL] [Abstract][Full Text] [Related]
9. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos.
Hinz VC; Grewig S; Schmidt BH
Neurochem Res; 1996 Mar; 21(3):331-7. PubMed ID: 9139239
[TBL] [Abstract][Full Text] [Related]
10. Studies of the mode of action of metrifonate and DDVP in schistosomes - cholinesterase activity and the hepatic shift.
Bloom A
Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():109-13. PubMed ID: 7344403
[No Abstract] [Full Text] [Related]
11. Effects of the cholinesterase inhibitors donepezil and metrifonate on scopolamine-induced impairments in the spatial cone field orientation task in rats.
van der Staay FJ; Bouger PC
Behav Brain Res; 2005 Jan; 156(1):1-10. PubMed ID: 15474645
[TBL] [Abstract][Full Text] [Related]
12. Clinical toxicosis and erythrocyte cholinesterase inhibition of trichlorfon combined with mebendazole in horses.
Gingerich DA; Mia AS
Am J Vet Res; 1981 Sep; 42(9):1645-50. PubMed ID: 7325477
[TBL] [Abstract][Full Text] [Related]
13. Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.
Mega MS; Cummings JL; O'Connor SM; Dinov ID; Reback E; Felix J; Masterman DL; Phelps ME; Small GW; Toga AW
Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):63-8. PubMed ID: 11234910
[TBL] [Abstract][Full Text] [Related]
14. An indirect cholinesterase inhibitor, metrifonate, increases neocortical EEG arousal in rats.
Björklund M; Jäkälä P; Schmidt B; Riekkinen M; Koivisto E; Riekkinen P
Neuroreport; 1996 Apr; 7(5):1097-101. PubMed ID: 8804059
[TBL] [Abstract][Full Text] [Related]
15. Preclinical pharmacology of metrifonate.
Jann MW
Pharmacotherapy; 1998; 18(2 Pt 2):55-67; discussion 79-82. PubMed ID: 9543466
[TBL] [Abstract][Full Text] [Related]
16. Effect on neuromuscular transmission of repeated administration of an organophosphorus compound, metrifonate, during treatment of children with urinary schistosomiasis.
Maxwell IC; Le Quesne PM; Ekue JM; Biles JE
Neurotoxicology; 1981 Dec; 2(4):687-701. PubMed ID: 6281697
[TBL] [Abstract][Full Text] [Related]
17. Effect of metrifonate on neuromuscular transmission.
Le Quesne PM; Maxwell IC
Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():99-104. PubMed ID: 6283788
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of brain cholinesterase inhibition following metrifonate administration.
Dachir S; Schmidt BH; Levy A
Neurochem Res; 1999 Aug; 24(8):1075-80. PubMed ID: 10478948
[TBL] [Abstract][Full Text] [Related]
19. Effect of subchronic metrifonate treatment on cerebral glucose metabolism in young and aged rats.
Poindessous-Jazat F; Schmidt BH; Bassant MH
Eur J Pharmacol; 1998 Dec; 363(1):17-28. PubMed ID: 9877077
[TBL] [Abstract][Full Text] [Related]
20. Effect of metrifonate on blood cholinesterases in children during the treatment of schistosomiasis.
Davis RP; Bailey DR
Bull World Health Organ; 1972; 46(6):747-59. PubMed ID: 4538536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
